Literature DB >> 25388787

Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach.

Andrey Zaytsev1, Barry Dodd1, Matteo Magnani2, Chiara Ghiron2, Bernard T Golding1, Roger J Griffin1, Junfeng Liu3, Xiaohong Lu3, Iolanda Micco2, David R Newell3, Alessandro Padova2, Graeme Robertson2, John Lunec3, Ian R Hardcastle1.   

Abstract

Two libraries of substituted benzimidazoles were designed using a 'scaffold-hopping' approach based on reported MDM2-p53 inhibitors. Substituents were chosen following library enumeration and docking into an MDM2 X-ray structure. Benzimidazole libraries were prepared using an efficient solution-phase approach and screened for inhibition of the MDM2-p53 and MDMX-p53 protein-protein interactions. Key examples showed inhibitory activity against both targets.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  drug design; drug discovery; protein-protein interaction; structure-based drug design; virtual screening

Mesh:

Substances:

Year:  2014        PMID: 25388787     DOI: 10.1111/cbdd.12474

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.

Authors:  Lina S Schneider; Melanie Ulrich; Thorsten Lehr; Dirk Menche; Rolf Müller; Karin von Schwarzenberg
Journal:  Mol Oncol       Date:  2016-04-27       Impact factor: 6.603

2.  Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.

Authors:  Maciej Pawel Ciemny; Aleksander Debinski; Marta Paczkowska; Andrzej Kolinski; Mateusz Kurcinski; Sebastian Kmiecik
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

Review 3.  Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets.

Authors:  Emil Bulatov; Almaz Zagidullin; Aygul Valiullina; Regina Sayarova; Albert Rizvanov
Journal:  Front Pharmacol       Date:  2018-05-08       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.